Evaluating vaccine effectiveness against Omicron BA.5 and BA

Researchers estimated the vaccine effectiveness (VE) of the primary and booster doses of COVID-19 vaccines against reinfection by Omicron BA.5 and BA.2 lineages and severe post-infection outcomes.

Related Keywords

Portugal , Portuguese , Aimee Molineux , Neha Mathur , Neha Mathuraug , International Classification Of Diseases , European Center , Portuguese National Institute Of Health , World Health Organization , National Death Certificate Information System , Cohort Study Using Electronic Health Records , National Health Service , Preventing Infections , Image Credit , Disease Prevention , Portuguese National Institute , Integrated Hospital Information System , International Classification , Coronavirus Disease Covid 19 , Micron , Vaccine , Fell , Coronavirus , Covid 19 , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,